武田制药 TAK
$21.02 −$0.17 (-0.80%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $21.74 +3.43%
开盘$20.62
昨收$21.19
当日区间$20.57 – $21.09
成交量2.97M
市值$67.36B
市盈率（TTM）296.1
股息率1.49%
基本面
最新报告季度：Q2, ended Sep 2026 · 报告货币为JPY
营收¥1.19T+6.7% YoY
营业利润¥285.14B+195.7% YoY
净利润¥192.46B+1,740.9% YoY
摊薄每股收益¥59.49+1,619.5% YoY
自由现金流¥248.55B-23.6% YoY
经营现金流¥304.27B
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率65.8%
营业利润率14.3%
净利率0.9%
净资产收益率0.6%
资产收益率0.3%
投入资本回报率1.1%
流动比率1.15
负债/资产比率51.4%
现金及投资¥454.40B
总负债¥4.58T
净现金（净负债）-¥4.12T
自由现金流/营收9.2%
营收构成
2027/Q1 季度
按业务线
该公司以本国货币报告财务数据，并非美元。以下数字均标注了实际货币单位，未自动换算。
利润表
| 项目 | 2027 Q2 (JPY) |
2027 Q1 (JPY) |
2026 ANNUAL (JPY) |
2026 Q4 (JPY) |
2026 Q3 (JPY) |
|---|---|---|---|---|---|
| 报告营业总收入 | ¥1.19T | ¥1.22T | ¥4.51T | ¥1.09T | ¥1.19T |
| 营业总收入 | ¥1.19T | ¥1.22T | ¥4.51T | ¥1.09T | ¥1.19T |
| 营业成本 | ¥392.09B | ¥406.68B | ¥1.57T | ¥405.70B | ¥401.15B |
| 毛利润 | ¥795.00B | ¥813.22B | ¥2.93T | ¥688.84B | ¥790.55B |
| 营业费用 | ¥509.86B | ¥611.81B | ¥2.47T | ¥646.77B | ¥649.16B |
| 销售及管理费用 | ¥271.71B | ¥286.51B | ¥1.08T | ¥292.00B | ¥282.78B |
| 研发费用 | ¥171.23B | ¥167.40B | ¥675.92B | ¥195.32B | ¥175.23B |
| 折旧、摊销与折耗 | ¥107.59B | ¥110.93B | ¥633.54B | ¥154.84B | ¥141.91B |
| -折旧与摊销 | ¥107.59B | ¥110.93B | ¥633.54B | ¥154.84B | ¥141.91B |
| 其他营业费用 | -¥40.67B | ¥46.97B | ¥76.00B | ¥4.62B | ¥49.23B |
| 营业利润 | ¥285.14B | ¥201.42B | ¥464.45B | ¥42.07B | ¥141.39B |
| 非经营性利息净收入（支出） | -¥48.81B | -¥39.24B | -¥143.77B | -¥35.88B | -¥35.76B |
| 非经营性利息收入 | ¥14.57B | ¥24.61B | ¥16.88B | -¥189.15B | ¥87.87B |
| 非经营性利息支出 | ¥63.38B | ¥63.85B | ¥148.12B | -¥165.80B | ¥123.63B |
| 其他收入（支出） | -¥80.36B | ¥538.00M | -¥463.03B | -¥461.22B | ¥28.23B |
| 权益法投资收益 | -¥542.00M | ¥538.00M | -¥2.18B | -¥361.00M | ¥799.00M |
| 税前利润 | ¥155.97B | ¥162.72B | -¥142.36B | -¥455.02B | ¥133.86B |
| 税费 | -¥36.49B | ¥49.46B | ¥9.77B | -¥86.62B | ¥30.13B |
| 净利润 | ¥192.46B | ¥113.26B | -¥152.13B | -¥368.41B | ¥103.73B |
| 持续经营利润 | ¥192.46B | ¥113.26B | -¥152.13B | -¥368.41B | ¥103.73B |
| 少数股东权益 | ¥29.00M | ¥60.00M | ¥264.00M | ¥62.00M | ¥94.00M |
| 归属母公司净利润 | ¥192.43B | ¥113.20B | -¥152.39B | -¥368.47B | ¥103.64B |
| 归属普通股股东净利润 | ¥192.43B | ¥113.20B | -¥152.39B | -¥368.47B | ¥103.64B |
| 基本每股收益 | ¥60.44 | ¥35.83 | -¥48.38 | -¥117.03 | ¥32.87 |
| 摊薄每股收益 | ¥59.49 | ¥35.27 | -¥48.38 | -¥117.03 | ¥32.34 |
| 每股股息 | ¥0.00 | ¥0.00 | ¥97.15 | ¥49.28 | ¥0.00 |
| 其他财务成本合计 | – | – | ¥12.53B | – | – |
| 证券出售收益 | – | – | ¥6.14B | – | – |
| 特殊收益（费用） | – | – | -¥466.99B | – | – |
| -减：重组及并购费用 | – | – | ¥71.82B | – | – |
| -减：其他特殊支出 | – | – | ¥412.23B | – | – |
| -减：核销 | – | – | ¥1.36B | – | – |
| -业务出售收益 | – | – | ¥18.27B | – | – |
| -固定资产出售收益 | – | – | ¥165.00M | – | – |
资产负债表
| 项目 | 2027 Q2 (JPY) |
2027 Q1 (JPY) |
2026 ANNUAL (JPY) |
2026 Q4 (JPY) |
2026 Q3 (JPY) |
|---|---|---|---|---|---|
| 总资产 | ¥15.27T | ¥15.66T | ¥15.51T | ¥15.51T | ¥15.41T |
| 流动资产合计 | ¥3.00T | ¥3.15T | ¥3.09T | ¥3.09T | ¥3.12T |
| 现金及现金等价物与短期投资 | ¥454.40B | ¥527.58B | ¥636.94B | ¥636.94B | ¥761.94B |
| -现金及现金等价物 | ¥418.53B | ¥460.98B | ¥595.05B | ¥595.05B | ¥654.94B |
| -短期投资 | ¥35.87B | ¥66.60B | ¥41.89B | ¥41.89B | ¥107.00B |
| 应收款 | ¥910.25B | ¥956.14B | ¥876.35B | ¥876.35B | ¥757.92B |
| -应收账款 | ¥872.68B | ¥930.38B | ¥977.36B | ¥977.36B | ¥736.46B |
| -应收税款 | ¥37.56B | ¥25.76B | ¥32.04B | ¥32.04B | ¥21.46B |
| 存货 | ¥1.44T | ¥1.45T | ¥1.40T | ¥1.40T | ¥1.41T |
| 其他流动资产 | ¥178.08B | ¥188.78B | ¥162.64B | ¥162.64B | ¥175.78B |
| 非流动资产合计 | ¥12.27T | ¥12.51T | ¥12.42T | ¥12.42T | ¥12.29T |
| 固定资产净值 | ¥2.28T | ¥2.14T | ¥2.12T | ¥2.12T | ¥2.08T |
| 投资及预付款 | ¥408.26B | ¥473.22B | ¥448.74B | ¥448.74B | ¥434.17B |
| -可供出售证券 | ¥399.64B | ¥463.14B | ¥439.94B | ¥439.94B | ¥423.98B |
| -长期股权投资 | ¥8.62B | ¥10.08B | ¥8.80B | ¥8.80B | ¥10.19B |
| 商誉及其他无形资产 | ¥8.90T | ¥9.28T | ¥9.23T | ¥9.23T | ¥9.27T |
| -商誉 | ¥5.68T | ¥5.89T | ¥5.81T | ¥5.81T | ¥5.75T |
| -其他无形资产 | ¥3.22T | ¥3.39T | ¥3.42T | ¥3.42T | ¥3.52T |
| 一年以上递延资产 | ¥607.52B | ¥539.15B | ¥546.26B | ¥546.26B | ¥427.49B |
| 其他非流动资产 | ¥74.10B | ¥80.30B | ¥77.01B | ¥77.01B | ¥77.80B |
| 负债合计 | ¥7.85T | ¥8.10T | ¥8.08T | ¥8.08T | ¥7.76T |
| 流动负债合计 | ¥2.60T | ¥2.76T | ¥2.83T | ¥2.83T | ¥2.61T |
| 应付款 | ¥603.28B | ¥564.72B | ¥589.23B | ¥589.23B | ¥615.93B |
| -应付账款 | ¥486.20B | ¥446.78B | ¥324.37B | ¥324.37B | ¥467.59B |
| -应付税款合计 | ¥117.08B | ¥117.93B | ¥97.88B | ¥97.88B | ¥148.34B |
| 短期债务及融资租赁负债 | ¥400.97B | ¥519.97B | ¥512.16B | ¥512.16B | ¥583.15B |
| -一年内到期债务 | ¥400.97B | ¥519.97B | ¥512.16B | ¥512.16B | ¥583.15B |
| 一年内预提费用 | ¥962.14B | ¥995.05B | ¥998.50B | ¥998.50B | ¥572.13B |
| 其他流动负债 | ¥637.16B | ¥684.81B | ¥732.19B | ¥732.19B | ¥838.98B |
| 非流动负债合计 | ¥5.25T | ¥5.34T | ¥5.25T | ¥5.25T | ¥5.15T |
| 长期债务及融资租赁负债 | ¥4.17T | ¥4.42T | ¥4.37T | ¥4.37T | ¥4.27T |
| -长期债务 | ¥4.17T | ¥4.42T | ¥4.37T | ¥4.37T | ¥4.27T |
| 非流动负债 | ¥34.38B | ¥37.93B | ¥37.55B | ¥37.55B | ¥34.06B |
| 一年以上递延负债 | ¥24.29B | ¥27.04B | ¥26.80B | ¥26.80B | ¥31.28B |
| 员工福利 | ¥132.19B | ¥141.79B | ¥143.68B | ¥143.68B | ¥150.60B |
| 其他非流动负债 | ¥885.24B | ¥713.09B | ¥671.07B | ¥671.07B | ¥665.12B |
| 股东权益合计 | ¥7.42T | ¥7.56T | ¥7.43T | ¥7.43T | ¥7.64T |
| 股东权益 | ¥7.42T | ¥7.56T | ¥7.43T | ¥7.43T | ¥7.64T |
| 股本 | ¥1.72T | ¥1.70T | ¥1.70T | ¥1.70T | ¥1.69T |
| -普通股 | ¥1.72T | ¥1.70T | ¥1.70T | ¥1.70T | ¥1.69T |
| 资本公积 | ¥1.76T | ¥1.79T | ¥1.78T | ¥1.78T | ¥1.75T |
| 留存收益 | ¥859.25B | ¥667.01B | ¥712.38B | ¥712.38B | ¥1.10T |
| 减：库存股 | ¥20.91B | ¥47.44B | ¥49.13B | ¥49.13B | ¥49.12B |
| 不影响留存收益的损益 | -¥3.22B | -¥11.06B | -¥2.85B | -¥2.85B | -¥2.94B |
| 其他权益权益 | ¥3.10T | ¥3.46T | ¥3.30T | ¥3.30T | ¥3.15T |
| 少数股东权益 | ¥991.00M | ¥989.00M | ¥1.21B | ¥1.21B | ¥1.15B |
| -其他应收款 | – | – | ¥36.29B | ¥36.29B | – |
| -应收款调整准备 | – | – | -¥169.33B | -¥169.33B | – |
| -固定资产原值 | – | – | ¥3.65T | ¥3.65T | – |
| -累计折旧 | – | – | -¥1.53T | -¥1.53T | – |
| -其他应付款 | – | – | ¥166.98B | ¥166.98B | – |
| 长期应付账款及其他应付款 | – | – | – | – | ¥3.27B |
现金流量表
| 项目 | 2027 Q2 (JPY) |
2027 Q1 (JPY) |
2026 ANNUAL (JPY) |
2026 Q4 (JPY) |
2026 Q3 (JPY) |
|---|---|---|---|---|---|
| 经营活动现金流 | ¥304.27B | ¥127.62B | ¥1.04T | ¥74.53B | ¥373.25B |
| 持续经营经营活动现金流净额 | ¥304.27B | ¥127.62B | ¥1.04T | ¥74.53B | ¥373.25B |
| 持续经营净利润 | ¥192.46B | ¥113.26B | -¥152.13B | -¥368.41B | ¥103.73B |
| 持续经营损益 | ¥9.38B | -¥6.54B | -¥13.02B | ¥1.82B | -¥441.00M |
| 折旧、折耗与摊销 | ¥164.43B | ¥163.04B | ¥721.13B | ¥163.87B | ¥190.64B |
| 递延税款 | -¥36.49B | ¥49.46B | ¥9.77B | -¥86.62B | ¥30.13B |
| 其他非现金项目 | ¥2.38B | -¥44.76B | ¥228.84B | ¥106.40B | ¥85.09B |
| 营运资金变动 | ¥11.69B | -¥181.57B | ¥199.91B | ¥251.00B | -¥39.33B |
| -应收款变动 | ¥40.65B | -¥70.97B | -¥70.17B | -¥97.52B | -¥10.94B |
| -存货变动 | -¥42.25B | -¥33.41B | -¥61.29B | ¥18.70B | -¥37.96B |
| -应付账款及应计费用变动 | ¥9.27B | -¥22.91B | -¥3.15B | ¥4.80B | ¥3.29B |
| -其他流动负债变动 | ¥6.34B | -¥34.91B | -¥81.61B | -¥96.37B | ¥20.07B |
| -其他营运资金变动 | -¥2.33B | -¥19.38B | ¥416.12B | ¥421.38B | -¥13.79B |
| 投资活动现金流净额 | -¥21.07B | -¥87.70B | -¥369.14B | -¥58.02B | -¥229.80B |
| 持续经营投资活动现金流净额 | -¥21.07B | -¥87.70B | -¥369.14B | -¥58.02B | -¥229.80B |
| 固定资产购置及出售净额 | -¥44.33B | -¥52.72B | -¥169.55B | -¥46.31B | -¥41.62B |
| 无形资产购置及出售净额 | -¥11.03B | -¥49.43B | -¥238.66B | -¥18.03B | -¥180.74B |
| 业务购买及出售净额 | ¥12.07B | ¥10.46B | ¥33.58B | ¥515.00M | ¥3.36B |
| 投资购置及出售净额 | ¥17.03B | -¥747.00M | -¥10.40B | ¥723.00M | -¥13.37B |
| 其他投资变动净额 | ¥698.00M | -¥244.00M | -¥2.78B | -¥51.00M | -¥2.64B |
| 筹资活动现金流 | -¥311.02B | -¥180.35B | -¥496.82B | -¥77.49B | -¥192.45B |
| 持续经营筹资活动现金流净额 | -¥311.02B | -¥180.35B | -¥496.82B | -¥77.49B | -¥192.45B |
| 债务发行及偿还净额 | -¥250.02B | -¥11.29B | ¥1.08B | -¥25.62B | -¥9.89B |
| 普通股发行净额 | ¥0.00 | -¥1.01B | -¥51.60B | ¥0.00 | ¥0.00 |
| 已付现金股利 | -¥7.73B | -¥150.13B | -¥311.90B | -¥8.79B | -¥149.03B |
| 其他筹资费用净额 | -¥2.40B | -¥2.35B | -¥13.01B | -¥3.79B | -¥3.74B |
| 期末现金余额 | ¥418.53B | ¥460.98B | ¥595.05B | ¥595.05B | ¥654.94B |
| 现金净变动 | -¥27.83B | -¥140.43B | ¥175.47B | -¥60.98B | -¥48.99B |
| 期初现金余额 | ¥460.98B | ¥595.05B | ¥385.11B | ¥654.94B | ¥681.49B |
| 汇率变动影响 | -¥14.62B | ¥6.36B | ¥34.47B | ¥1.10B | ¥22.44B |
| 自由现金流 | ¥248.55B | ¥24.39B | ¥626.77B | ¥10.14B | ¥150.88B |
暂无评论——快来第一个聊聊 TAK。